The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage
Language English Country Austria Media print
Document type Clinical Trial, Journal Article
- MeSH
- Adult MeSH
- Injections, Intraventricular MeSH
- Vasospasm, Intracranial diagnosis etiology prevention & control MeSH
- Catheterization methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Nitroprusside administration & dosage MeSH
- Aged MeSH
- Subarachnoid Hemorrhage complications diagnosis drug therapy MeSH
- Subarachnoid Space drug effects MeSH
- Vasodilator Agents administration & dosage MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Names of Substances
- Nitroprusside MeSH
- Vasodilator Agents MeSH
OBJECTIVE: The aim of this study was to evaluate the effect of preventive and therapeutic use of subarachnoid sodium nitroprusside (SNP) administration in patients with non-traumatic subarachnoid haemorrhage (SAH). METHODS: All consecutive adult patients admitted in the period 2000-2003 with SAH, Hunt-Hess grade I-IV, indicated for neurosurgical intervention, were enrolled in the study. In the postoperative period they were treated with mechanical ventilation and triple H protocol with nimodipine. Subarachnoid preventive SNP was administred in initial dose of 1 mg by catheter inserted into basal cisterns during the neurosurgical procedure. The timing of following dosage was directed by the changes of respiratory parameters of brain tissue in the region of interest by multiparameter sensor (Codman Neurotrend) and findings of blood flow velocity on the level of circle of Willis were measured by transcranial doppler ultrasonography (TCD). RESULTS: 17 patients were enrolled to study. All patients survived. No brain infarction developed. The increase blood flow velocity was found in three patients. CONCLUSION: Preventive subarachnoid use of SNP in combination with multimodal monitoring might be a possible preventive strategy. Its efficacy has to be proved on a greater group of patients in the future. The therapeutical use of SNP requires an increase in application rate.
References provided by Crossref.org